Previous Next

News Releases    Health & Medical

Translations: 


Health & Medical Results: 2318 item(s)
LONDON, Nov. 15, 2022 /PRNewswire-AsiaNet/-- In a landmark new Global State of Tobacco Harm Reduction (GSTHR) report, experts are calling on global policymakers to seize the opportunity to bring about an end to smoking, which every year kills eight million people worldwide. Despite years of ...
ANNAPOLIS, Md., Nov. 15, 2022 /PRNewswire-AsiaNet/ -- Alphyn Biologics ( https://c212.net/c/link/?t=0&l=en&o=3709054-1&h=2795132862&u=https%3A%2F%2Falphynbiologics.com%2F&a=Alphyn+Biologics ), a clinical-stage dermatology company developing first-in-class multi-target therapeutics, announced today th...
LONDON, November 14, 2021 /PRNewswire-AsiaNet/-- - Now Available in Europe, parts of the Middle East, Asia, Latin America, and Africa - Early customers include GP offices and other community-based healthcare settings - Latest figures, released as part of World Diabetes Day, reveal that 1 ...
TEL AVIV, Israel and RALEIGH, NC, November 14, 2022 /PRNewswire-AsiaNet/ -- Strong preclinical data, recently published in the International Journal of Molecular Sciences, from eight U.S government-funded in-vivo opaganib studies, supports opaganib's potential as a nuclear radiation injury therapeutic for homeland securit...
MILAN, November, 14, 2022, /PRNewswire-AsiaNet/-- Sentinel CH. SpA today announced the launch of SENTiNAT(R) 200, the fully automated sample to result system, and SENT-NAT(R) SN200 Real-Time PCR assays for the quantitative detection of 10 viruses. SENTiNAT(R) 200 and STAT-NAT(R) SN200 kits repres...
ABERDEEN, Scotland and SINGAPORE, Nov. 14, 2022 /PRNewswire-AsiaNet/ -- - Substantial investment of USD119 million achieved by TauRx through a warrants exercise triggered by the announcement of LUCIDITY results in October, supporting HMTM regulatory submissions in UK, US and Canada, and preparation for market availabi...
TAIPEI, Taiwan, Nov. 11, 2022 /PRNewswire-AsiaNet/ -- Lotus Pharmaceutical (1795: TT), a multinational pharmaceutical company, today reported its financial results for the third quarter ended 30 September 2022. Third quarter financial highlights: - Third quarter 2022 is the best quarter ever in...
PERUGIA, Italy, Nov. 9, 2022, /PRNewswire-AsiaNet/-- INT-787 is a selective next generation FXR agonist invented by TES Pharma and licensed to Intercept Pharmaceuticals INT-787 has shown strong anti-fibrotic and anti-inflammatory effects in animal models TES Pharma is dedicated to the identifi...
GAITHERSBURG, Md., Nov. 8, 2022 /PRNewswire-AsiaNet/ -- -- The Novavax BA.1 vaccine candidate met its primary strain-change endpoint allowing for development of variant vaccines, if necessary -- Novavax' prototype vaccine induced broad immune response against original Wuhan, BA.1, and BA.5 strains --...
PARIS, Nov. 8, 2022 /PRNewswire-AsiaNet/ -- - The ambitious EU initiative has already secured 2 billion euros of co-investment capabilities and has supported 60 innovative Biotech, Medtech & digital health start-ups to get to market or expand into new territories. - EIT Health, co-operator...

Previous Page Page 7 of 232 Next Page ...  2  3  4  5  6  7  8  9  10  11  ... Go to page Go